MTWM
ABBV icon

Masso Torrence Wealth Management’s AbbVie ABBV Stock Holding History

Masso Torrence Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.17M Buy
9,360
+162
+2% +$33K 0.9% 27
2025
Q2 		$1.71M Sell
9,198
-16
-0.2% -$2.97K 0.79% 29
2025
Q1 		$1.93M Sell
9,214
-21
-0.2% -$4.08K 1.03% 24
2024
Q4 		$1.64M Sell
9,235
-561
-6% -$103K 0.86% 28
2024
Q3 		$1.93M Sell
9,796
-120
-1% -$22.4K 1.04% 23
2024
Q2 		$1.7M Sell
9,916
-331
-3% -$54.8K 0.94% 24
2024
Q1 		$1.87M Sell
10,247
-1,616
-14% -$279K 1.11% 23
2023
Q4 		$1.84M Sell
11,863
-1,860
-14% -$271K 1.26% 21
2023
Q3 		$2.05M Buy
13,723
+76
+0.6% +$11.2K 1.57% 22
2023
Q2 		$1.84M Sell
13,647
-558
-4% -$81.8K 1.33% 24
2023
Q1 		$2.26M Sell
14,205
-250
-2% -$38.2K 1.79% 20
2022
Q4 		$2.34M Sell
14,455
-2,289
-14% -$351K 1.86% 18
2022
Q3 		$2.25M Buy
16,744
+580
+4% +$83.2K 1.98% 19
2022
Q2 		$2.48M Sell
16,164
-603
-4% -$92.1K 2.18% 18
2022
Q1 		$2.72M Buy
16,767
+233
+1% +$33.8K 2.18% 17
2021
Q4 		$2.24M Buy
+16,534
New +$1.95M 1.57% 21

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Masso Torrence Wealth Management's ABBV Position: Q3 2025 in Review

Masso Torrence Wealth Management increased its AbbVie (ABBV) stake by 1.8% in Q3 2025, buying an estimated $33K and bringing the position to 9,360 shares worth $2.17M. The position accounts for 0.9% of the portfolio, ranked #27.

Masso Torrence Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 16 quarters since. The position peaked at $2.72M in Q1 2022. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Masso Torrence Wealth Management held 9,360 shares of AbbVie worth $2.17M as of Q3 2025.
  • Masso Torrence Wealth Management bought 162 AbbVie shares in Q3 2025, an estimated $33K.
  • AbbVie made up 0.9% of Masso Torrence Wealth Management's portfolio in Q3 2025, its #27 holding.
  • Masso Torrence Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 16 quarters since.
  • Masso Torrence Wealth Management's AbbVie position peaked at $2.72M in Q1 2022.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Masso Torrence Wealth Management's 13F filing for Q3 2025, filed 20 Oct 2025.